Search Results - "Lottin, M."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Compliance with good practice guidelines for the prevention of vascular access infections: the multi-centre PHYDEL survey in French haemodialysis units by Habihirwe, P., Marini, H., Wurtz, B., Vermeulin, T., Lottin, M., Gehanno, J.F., Boulet, L., Vergnes, H., Edet, S., Guet, L., Le Roy, F., Merle, V.

    Published in The Journal of hospital infection (01-12-2023)
    “…French guidelines for the prevention of vascular access infections in a haemodialysis setting were released in 2005. Compliance with these guidelines is…”
    Get full text
    Journal Article
  2. 2

    Lack of effect of a poster-based intervention to reduce the number of blood culture samples collected by Boulet, L., Vermeulin, T., Vasiliu, A., Gillibert, A., Lottin, M., Frébourg, N., Boyer, S., Merle, V.

    Published in Médecine et maladies infectieuses (01-02-2020)
    “…•The issue of this article is of interest to prescribing physicians, infectious disease physicians, bacteriologists, and hygienists. Recalling the guidelines…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Reassessment of antibiotic therapy in hospitals by Lucas, M., Germain, J.-M., Rémy, E., Lottin, M., Etienne, M., Czernichow, P., Merle, V.

    Published in Médecine et maladies infectieuses (01-09-2017)
    “…French national guidelines state that antibiotic therapies should be reassessed between 48 and 72hours after treatment initiation and that reassessment of…”
    Get full text
    Journal Article
  5. 5

    TEMPORARY REMOVAL: PO-50: Molecular landscape of the coagulome of oral squamous cell carcinoma by Lottin, M, Soudet, S, Sevestre, M-A, Saidak, Z, Galmiche, A

    Published in Thrombosis research (01-05-2022)
    “…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Pertinence de la prescription des antibiotiques actifs sur les staphylocoques résistant à la méticilline dans un CHU by Lottin, M., Fiaux, E., Gouin, P., Beduneau, G., Braud, H., Gastaldi, G., Tiret, I., Oudinot, X., Merle, V., Caron, F.

    Published in Médecine et maladies infectieuses (01-06-2018)
    “…Les antibiotiques (ATB) actifs sur les staphylocoques méticilline résistant (anti-SARM) sont considérés comme des ATB critiques de réserve et font l’objet…”
    Get full text
    Journal Article
  9. 9